Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Net Loss per Share
Antidilutive securities excluded from common stock (in shares)	6,697,566	5,546,555
Unvested restricted common stock
Net Loss per Share
Antidilutive securities excluded from common stock (in shares)	1,268,461	463,964
Unvested shares from early exercises
Net Loss per Share
Antidilutive securities excluded from common stock (in shares)	14,745	53,741
Stock Options
Net Loss per Share
Antidilutive securities excluded from common stock (in shares)	5,414,360	5,028,850

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration